Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions

Lung Cancer

Volumn 68, Issue 1, 2010, Pages 39-43

  Flores Staino, Carmen ^a   Darai Ramqvist, Eva ^a   Dobra, Katalin ^a   Hjerpe, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Effusion cytology; FISH; Malignant mesothelioma; p16 gene; Ploidy

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ANEUPLOIDY; ARTICLE; CANCER CELL; CHROMOSOME 9P; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCUS; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; METASTASIS; PLEURA EFFUSION; PRIORITY JOURNAL;

ANEUPLOIDY; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENES, P16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MESOTHELIOMA; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; REAGENT KITS, DIAGNOSTIC; SEQUENCE DELETION; SOLITARY FIBROUS TUMOR, PLEURAL;

EID: 77649341041     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.05.004     Document Type: Article

References (10)

1. Brock M.V., Hooker C.M., Young R., Guo M., Han Y., Ames S.E., et al. Can we improve the cytologic examination of pleural effusions using molecular analysis?. Ann Thorac Surg 80 (2005) 1241-1247
2. Mutsaers S.E. Mesothelial cells: their structure, function and role in serosal repair. Respirology 7 (2002) 171-191
3. Foley-Comer A.J., Herrick S.E., Al-Mishlab T., Prêle C.M., Laurent G.J., and Mutsaers S.E. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 115 (2002) 1383-1389
4. Illei P.B., Ladanyi M., Rusch V.W., and Zakowski M.F. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer 99 (2003) 51-56
5. Brockstedt U., Gulyas M., Dobra K., Dejmek A., and Hjerpe A. An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 114 (2000) 203-209
6. Nurminen M., Dejmek A., Mårtensson G., Thylén A., and Hjerpe A. Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clin Chem 40 5 (1994) 777-780
7. Onofre F.B., Onofre A.S., Pomjanski N., Buckstegge B., Grote H.J., and Böcking A. 9p21 deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM and AgNOR analysis. Cancer (Cancer Cytopathol) 114 3 (2008) 204-215
8. Shin H.J., Shin D.M., Tarco E., and Sneige N. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma. Cancer 9 (2003) 233-239
9. Lindholm P.M., Salmenkivi K., Vauhkonen H., Nicholson A.G., Anttila S., and Kinnula V.L. Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH. Cytogenet Genome Res 119 1-2 (2007) 46-52
10. Segal A., Whitaker D., Sterrett G.F., Frost F.A., Robinson B.W.S., Olsen N., et al. Cytological diagnosis of pleural malignant mesothelioma. The 9th international conference of the IMIG (International Mesothelioma Interest Group). Amsterdam, The Netherlands, September 25-27 (2008)